Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zai Lab Ltd Director's Dealing 2021

Jan 4, 2021

31208_dirs_2021-01-04_848824ea-d051-4228-96ad-0720b13eac0a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2021-01-01

Reporting Person: Du Ying (Director, Chairwoman & CEO)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 1024653 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $0.60 2025-10-22 Ordinary Shares (1555832) Direct
Stock Option (Right to Buy) $1.20 2026-03-09 Ordinary Shares (604376) Direct
Stock Option (Right to Buy) $1.74 2026-08-25 Ordinary Shares (922184) Direct
Stock Option (Right to Buy) $20.90 2028-03-28 Ordinary Shares (350000) Direct
Stock Option (Right to Buy) $38.93 2029-03-08 Ordinary Shares (300000) Direct
Stock Option (Right to Buy) $44.94 2030-03-12 Ordinary Shares (250000) Direct

Footnotes

F1: The option was fully vested as of 10/22/2020. The number in Column 3 represents the options that remain outstanding from the grant of 1,739,166 shares.

F2: The option vests in equal annual installments over five years beginning on 03/09/2017, the first anniversary of the date of grant.

F3: The option vests in equal annual installments over five years beginning on 08/25/2017, the first anniversary of the date of grant.

F4: The option vests in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant.

F5: The option vests in equal annual installments over five years beginning on 03/08/2020, the first anniversary of the date of grant.

F6: The option vests in equal annual installments over five years beginning on 03/12/2021, the first anniversary of the date of grant.